| 000 | 01667 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250516034732.0 | ||
| 264 | 0 | _c20110817 | |
| 008 | 201108s 0 0 eng d | ||
| 022 | _a1520-4804 | ||
| 024 | 7 |
_a10.1021/jm200156c _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDuncan, Kelly E | |
| 245 | 0 | 0 |
_aDiscovery and characterization of a nonphosphorylated cyclic peptide inhibitor of the peptidylprolyl isomerase, Pin1. _h[electronic resource] |
| 260 |
_bJournal of medicinal chemistry _cJun 2011 |
||
| 300 |
_a3854-65 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aBinding Sites |
| 650 | 0 | 4 | _aCatalytic Domain |
| 650 | 0 | 4 | _aDrug Discovery |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xchemical synthesis |
| 650 | 0 | 4 | _aMolecular Structure |
| 650 | 0 | 4 | _aMolecular Targeted Therapy |
| 650 | 0 | 4 | _aNIMA-Interacting Peptidylprolyl Isomerase |
| 650 | 0 | 4 | _aPeptide Library |
| 650 | 0 | 4 |
_aPeptides, Cyclic _xchemical synthesis |
| 650 | 0 | 4 |
_aPeptidylprolyl Isomerase _xantagonists & inhibitors |
| 650 | 0 | 4 | _aPhosphorylation |
| 650 | 0 | 4 | _aProtein Binding |
| 650 | 0 | 4 | _aProtein Conformation |
| 650 | 0 | 4 | _aSubstrate Specificity |
| 700 | 1 | _aDempsey, Brian R | |
| 700 | 1 | _aKillip, Lauren E | |
| 700 | 1 | _aAdams, Jarrett | |
| 700 | 1 | _aBailey, Melanie L | |
| 700 | 1 | _aLajoie, Gilles A | |
| 700 | 1 | _aLitchfield, David W | |
| 700 | 1 | _aBrandl, Christopher J | |
| 700 | 1 | _aShaw, Gary S | |
| 700 | 1 | _aShilton, Brian H | |
| 773 | 0 |
_tJournal of medicinal chemistry _gvol. 54 _gno. 11 _gp. 3854-65 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1021/jm200156c _zAvailable from publisher's website |
| 999 |
_c20808879 _d20808879 |
||